Publications

Found 6 results
Filters: Author is Y.B. Ma  [Clear All Filters]
2013
Y. B. Ma, Hao, C. X., and Chang, H. Y., Nucleotide mismatches of foot-and-mouth disease virus during replication, vol. 12, pp. 1022-1027, 2013.
Beard CW and Mason PW (2000). Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J. Virol. 74: 987-991. http://dx.doi.org/10.1128/JVI.74.2.987-991.2000 PMid:10623761 PMCid:111619   Belsham GJ (2005). Translation and replication of FMDV RNA. Curr. Top. Microbiol. Immunol. 288: 43-70. http://dx.doi.org/10.1007/3-540-27109-0_3 PMid:15648174   Carrillo C, Tulman ER, Delhon G, Lu Z, et al. (2005). Comparative genomics of foot-and-mouth disease virus. J. Virol. 79: 6487-6504. http://dx.doi.org/10.1128/JVI.79.10.6487-6504.2005 PMid:15858032 PMCid:1091679   Drake JW and Holland JJ (1999). Mutation rates among RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 96: 13910-13913. http://dx.doi.org/10.1073/pnas.96.24.13910 PMid:10570172 PMCid:24164   Grubman MJ and Baxt B (2004). Foot-and-mouth disease. Clin. Microbiol. Rev. 17: 465-493. http://dx.doi.org/10.1128/CMR.17.2.465-493.2004 PMid:15084510 PMCid:387408   Kerr AW, Hall HK and Kozub S (2002). Doing Statistics with SPSS. vii. Thousand Oaks, California, London, 238.   Morgan JF (2007). p Value fetishism and use of the Bonferroni adjustment. Evid. Based Mental Health 10: 34-35. http://dx.doi.org/10.1136/ebmh.10.2.34 PMid:17459968   Parzen E (1960). Modern Probability Theory and its Applications. xv. A Wiley Publication in Mathematical Statistics. Wiley, New York, 464.
2010
H. G. Wang, Wang, J. L., Chang, P., Cao, F. L., Liu, X. C., Ma, Y. B., Zhai, G. X., and Gao, H. Q., Endothelial nitric oxide synthase gene polymorphisms and essential hypertension in Han Chinese, vol. 9, pp. 1896-1907, 2010.
Casas JP, Bautista LE, Humphries SE and Hingorani AD (2004). Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation 109: 1359-1365. http://dx.doi.org/10.1161/01.CIR.0000121357.76910.A3 PMid:15007011   Casas JP, Cavalleri GL, Bautista LE, Smeeth L, et al. (2006). Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am. J. Epidemiol. 164: 921-935. http://dx.doi.org/10.1093/aje/kwj302 PMid:17018701   Dosh SA (2002). The treatment of adults with essential hypertension. J. Fam. Pract. 51: 74-80. PMid:11927069   Forte P, Copland M, Smith LM, Milne E, et al. (1997). Basal nitric oxide synthesis in essential hypertension. Lancet 349: 837-842. http://dx.doi.org/10.1016/S0140-6736(96)07631-3   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919   Huang HB, Lin LX and Chen MQ (2002). Association of polymorphism of endothelial nitric oxide synthase gene with essential hypertension and type 2 diabetes mellitus. Chin. J. Endocrinol. Metab. 18: 16-19.   Huang PL, Huang Z, Mashimo H, Bloch KD, et al. (1995). Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242. http://dx.doi.org/10.1038/377239a0 PMid:7545787   Li DB, Hua Q, Pi L, Zou HQ, et al. (2003). Association of polymorphism of endothelial nitric oxide synthase gene with essential hypertension. Chin. J. Hypertens. 11: 552-554.   Li DB, Hua Q and Pi L (2004). Association of G894T polymorphism of endothelial nitric oxide synthase gene and essential hypertension. Chin. J. Hypertens. 12: 326-330.   Li DB, Hua Q and Pi L (2006). The relationship of T786C polymorphism of endothelial nitric oxide synthase gene to essential hypertension. J. Cap. Univ. Med. Sci. 27: 226-229.   Li DJ, Wu WF, Xu L, Jiang XB, et al. (2009). Effect of G894T mutation in the endothelial nitric oxide synthase gene and abnormality of waist-to-hip ratio on essential hypertension. Chin. Gen. Pract. 12: 1173-1175, 1178.   Liang Q, Yang XY, Yang G and Cui JH (2006). Association of angiotensinogen and endothelial nitric oxide synthase gene polymorphism with essential hypertension. J. Youjiang Med. Col. Nationalities 28: 341-343.   Liu HZ and Ha DW (2002). Relationship between 894G→T polymorphism of endothelial nitric oxide synthase gene and essential hypertension. J. Chin. Circ. 17: 42-44.   Ma HX, Xie ZX, Niu YH, Li ZY, et al. (2006). Single nucleotide polymorphisms in NOS3 A-922G, T-786C and G894T: a correlation study of the distribution of their allelic combinations with hypertension in Chinese Han population. Yi. Chuan 28: 3-10. PMid:16469708   Macaskill P, Walter SD and Irwig L (2001). A comparison of methods to detect publication bias in meta-analysis. Stat. Med. 20: 641-654. http://dx.doi.org/10.1002/sim.698 PMid:11223905   Mayer B and Hemmens B (1997). Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22: 477-481. http://dx.doi.org/10.1016/S0968-0004(97)01147-X   Miyahara K, Kawamoto T, Sase K, Yui Y, et al. (1994). Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur. J. Biochem. 223: 719-726. http://dx.doi.org/10.1111/j.1432-1033.1994.tb19045.x PMid:7519987   Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, et al. (1998). Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32: 3-8. http://dx.doi.org/10.1161/01.HYP.32.1.3 PMid:9674630   Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, et al. (2008). Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic. Biol. Med. 44: 1912-1918. http://dx.doi.org/10.1016/j.freeradbiomed.2008.02.004 PMid:18325347   Newhouse SJ, Wallace C, Dobson R, Mein C, et al. (2005). Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British genetics of hypertension study. Hum. Mol. Genet. 14: 1805-1814. http://dx.doi.org/10.1093/hmg/ddi187 PMid:15888480   Niu WQ, Qi Y, Zhang LT, Qi YX, et al. (2009). Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study. J. Hum. Hypertens. 23: 136-139. http://dx.doi.org/10.1038/jhh.2008.111 PMid:18769442   Pereira TV, Rudnicki M, Cheung BM, Baum L, et al. (2007). Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J. Hypertens. 25: 1763-1774. http://dx.doi.org/10.1097/HJH.0b013e3281de740d PMid:17762636   Schmidt HH and Walter U (1994). NO at work. Cell 78: 919-925. http://dx.doi.org/10.1016/0092-8674(94)90267-4   Tan JC, Zhu ZM, Zhu SJ, Yu CQ, et al. (2003). The GNB3 and eNOS gene polymorphisms in patients with essential hypertension. Chin. J. Cardiol. 31: 16-19.   Tang JL (2005). Selection bias in meta-analyses of gene-disease associations. PLoS. Med. 2: e409. http://dx.doi.org/10.1371/journal.pmed.0020409 PMid:16363911 PMCid:1285067   Thaha M, Pranawa, Yogiantoro M, Sutjipto, et al. (2008). Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin. Nephrol. 70: 144-154. PMid:18793530   Thomas GD, Zhang W and Victor RG (2001). Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. JAMA 285: 2055-2057. http://dx.doi.org/10.1001/jama.285.16.2055 PMid:11311074   Tobias A (1999). Assessing the influence of a single study in the meta-analysis estimate. Stata Tech. Bull. 8: 15-17.   Trikalinos TA, Salanti G, Khoury MJ and Ioannidis JP (2006). Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am. J. Epidemiol. 163: 300-309. http://dx.doi.org/10.1093/aje/kwj046 PMid:16410351   Tsukada T, Yokoyama K, Arai T, Takemoto F, et al. (1998). Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem. Biophys. Res. Commun. 245: 190-193. http://dx.doi.org/10.1006/bbrc.1998.8267 PMid:9535806   Wu XF and Huang QY (2009). The a/b polymorphism in the eNOS gene is associated with essential hypertension but not type 2 diabetes in hubei Han Chinese. Prog. Mod. Biomed. 9: 69-72.   Yuan H, Li QX, Ping YH and Liu GZ (2007). Polymorphisms of endothelial nitric oxide synthase NOS3 4a/b and HindIII restriction site of the Y-chromosome in essential hypertension. Chin. J. Lab. Med. 30: 392-394.   Zhao Q, Su SY, Chen SF, Li B, et al. (2006). Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese. Chin Med. J. 119: 1065-1071.   Zhao XY, Guo X, Qiu CC, Zhang DH, et al. (2005). Relationship of endothelial nitric oxide synthase gene polymorphism, the 27-bp repeat in intron 4 with essential hypertension of the northern Han nationality in China. Chin. J. Rehabil. Theory Pract. 11: 422-424.   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. http://dx.doi.org/10.1002/gepi.20048 PMid:15593093   Zintzaras E and Lau J (2008). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J. Clin. Epidemiol. 61: 634-645. http://dx.doi.org/10.1016/j.jclinepi.2007.12.011 PMid:18538260   Zintzaras E, Kitsios G and Stefanidis I (2006). Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 48: 700-710. http://dx.doi.org/10.1161/01.HYP.0000238124.91161.02 PMid:16940230